drugset / Trial / NCT01232413

A Study of the Effect of ASP1941 on Cardiac Repolarization in Healthy Subjects

NCT01232413

Phase 1 Completed 88 enrolled Astellas Pharma Inc
RandomizedCrossoverTriple-blind

Summary

The objective of this study is to evaluate the effect of repeat oral dosing of ASP1941 on electrocardiogram (ECG) measurements.

Timeline

Start
2010-09
Primary completion
2011-02
Completion
2011-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Moxifloxacin Small molecule 400 mg Oral
Subject ipragliflozin Small molecule 100 mg Oral
Subject ipragliflozin Small molecule 600 mg Oral

Indications

No indication recorded.